Abstract:OBJECTIVE:To investigate clinical outcomes of ultrasound-guided percutaneous radiofrequency ablation (USG-RFA) in patients with renal clear cell carcinoma.METHODS:Medical records of 34 patients who underwent USG-RFA of renal clear cell carcinoma at the Department of Urology of the Affiliated Drum Tower Hospital of Medical School of Nanjing University from May 2009 to January 2014 were retrospectively reviewed, including 28 male and 6 female patients aged between 25 and 85 years (mean age 60.7 years). Of the included cases, 16 had tumors located in the left kidney, 16 in the right, 1 in the solitary kidney, and 1 in the bilateral kidney. There were 35 tumors in this study totally. The maximum diameter of the tumors was 1.8 to 5.0 cm (mean (2.7 ± 0.3) cm), of which 32 cases of renal tumors were ≤ 4.0 cm and 3 cases of renal tumors were > 4.0 cm to 5.0 cm. Pathological diagnosis were acquired by ultrasound-guided percutaneous biopsy after USG-RFA. Contrast-enhanced ultrasound was used to evaluate tumor outcomes at the time of the surgery, and multi-slice spiral CT enhanced scan and contrast-enhanced ultrasound were used to identify residues and recurrences after treatment.RESULTS:Treatments for all the patients were finished with short postoperative hospital stay about 3-5 days. No complications related to USG-RFA were encountered in any of the cases, such as perirenal fluid collection, perirenal hematoma, and peripheral organ damage. All the cases were diagnosed as clear cell carcinoma according to pathological results. The mean follow-up period was 29 ± 6 (range 3-59) months. Of the 35 USG-RFA-treated subjects, 32 tumors ≤ 4 cm reached the standard of complete treatment after one tumor was found with residue after the first month follow-up, and two tumors were noted recurrence at the 4 and 10 months follow-up after USG-RFA. Nonetheless, no residue or recurrence occurred after secondary treatment for these 3 tumors where pathological diagnosis were acquired again. The other 3 cases with tumors > 4.0 cm to 5.0 cm underwent USG-RFA twice or three times before reaching the standard of complete treatment, of which two had twice and one tumor had three times treatments. There was no carcinoma residue or recurrence during follow-up period.CONCLUSIONS:Percutaneous ultrasound-guided radiofrequency ablation for small renal mass (SRM) has satisfied clinical outcomes, with the advantage of less injury, lower complication rates and shorter recovery time for small size of renal clear cell carcinoma. USG-RFA may become the preferred treatment alternative for SRM.

Thermal Ablation for Renal Cell Carcinoma: Expert Consensus from the Asian Conference on Tumor Ablation

Asian Conference on Tumor Ablation Guidelines for Renal Cell Carcinoma

Expert Consensus Workshop Report: Guidelines for Thermal Ablation of Thyroid Tumors (2019 Edition)

Microwave Ablation of Renal Cell Carcinoma

[Expert consensus on thermal ablation of papillary thyroid cancer (2024 edition)]

[Ultrasound-Guided Percutaneous Radiofrequency Ablation Treatment for Renal Clear Cell Carcinoma].

Percutaneous microwave ablation of T1a renal cell carcinomas: A 10‐year single‐center retrospective review

Effectiveness of Thermal Ablation for Renal Cell Carcinoma after Prior Partial Nephrectomy

Evaluation on Efficacy of Radiofrequency Ablation for Renal Cell Carcinoma with Multi-Slice Helical CT

Radiofrequency Ablation, Cryoablation, and Microwave Ablation for the Treatment of Small Renal Masses: Efficacy and Complications

Radiofrequency ablation using real-time ultrasonography–computed tomography fusion imaging improves treatment outcomes for T1a renal cell carcinoma: Comparison with laparoscopic partial nephrectomy

Efficacy and safety of MWA versus RFA and CA for renal tumors: A systematic review and meta-analysis of comparison studies

Comparison of Radiofrequency Ablation Versus Cryoablation For T1 Renal Tumors: An Evidence-Based Analysis of Comparative Outcomes

[Expert consensus and operation specifications for thermal ablation in the treatment of primary hyperthyroidism]

Thermal ablation in cancer

Assessment of Local Tumor Progression After Image-Guided Thermal Ablation for Renal Cell Carcinoma

Assessment of Treatment Efficacy in Radiofrequency Ablation for Renal Tumors by Contrast-Enhanced Ultrasonography

Percutaneous Microwave Ablation vs Cryoablation for Small Renal Masses (≤4cm): 12-Year Experience at a Single Center

Radiofrequency Ablation of Renal Cell Carcinoma: Part 1, Indications, Results, and Role in Patient Management over a 6-Year Period and Ablation of 100 Tumors

The Application of Ultrasound-Guided Technology in Percutaneous Radiofrequency Ablation of Renal Tumors